Medtronic defibrillator batteries subject of FDA Class 1 recall
Physio-Control, a subsidiary of medical device manufacturer Medtronic, Inc., has begun a field correction effort to fix a possible battery power problem in its defibrillators. The medical devices are the subject of a “Class 1″ recall by the U.S. Food and Drug Administration (FDA), the highest-level recall made by the agency.
According to the FDA, approximately 43,000 Lifepak 20 and Lifepak 20e defibrillator/monitors worldwide may be affected. It is believed that at least one patient may have died as a result of the battery problem thus far.
